The mortality rate for malignant neoplasms of the colon, rectum, and anus in Brazil is projected to grow from 23,270 in 2024 to 25,610 in 2028. This reflects a steady annual increase in the number of deaths by approximately 2.5% each year. The compound annual growth rate (CAGR) over these five years is approximately 2.5%, highlighting a concerning upward trend in mortality from these diseases.
Future trends to watch for include the influence of healthcare policies aimed at early detection and prevention, advancements in medical treatments, and changes in lifestyle or environmental factors that might impact disease prevalence and outcomes.